The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-22
DOI
10.3389/fonc.2021.761379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential roles and prognostic significance of exosomes in cancer drug resistance
- (2021) Mostafa Mostafazadeh et al. Cell and Bioscience
- CMTM6 drives cisplatin resistance by regulating Wnt signaling through ENO-1/AKT/GSK3β axis
- (2021) Pallavi Mohapatra et al. JCI Insight
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Long non‑coding RNA OIP5‑AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR‑27b‑3p/TRIM14 axis
- (2021) Zhen Xiao et al. Experimental and Therapeutic Medicine
- Inhibition of Bruton’s tyrosine kinase as a therapeutic strategy for chemoresistant oral squamous cell carcinoma and potential suppression of cancer stemness
- (2021) Shao-Cheng Liu et al. Oncogenesis
- Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells
- (2021) Lichun Sun et al. Cancer Management and Research
- Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers
- (2021) Maureen Bernadach et al. BMC CANCER
- RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway
- (2021) Omprakash Shriwas et al. BRITISH JOURNAL OF CANCER
- LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway
- (2021) Jiandong Li et al. OncoTargets and Therapy
- Cancer: a mirrored room between tumor bulk and tumor microenvironment
- (2021) Pablo Hernández-Camarero et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Systematic screening identifies a TEAD4‐S100A13 axis modulating cisplatin sensitivity of oral squamous cell carcinoma cells
- (2021) Ruicen Li et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer
- (2021) Manzar Alam et al. LIFE SCIENCES
- DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG
- (2020) Omprakash Shriwas et al. APOPTOSIS
- Stathmin guides personalized therapy in oral squamous cell carcinoma
- (2020) Wu‐tong Ju et al. CANCER SCIENCE
- Cisplatin‐induced programmed cell death ligand‐2 expression is associated with metastasis ability in oral squamous cell carcinoma
- (2020) Shunichi Sudo et al. CANCER SCIENCE
- Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers
- (2020) Bahareh Kashani et al. IMMUNOLOGIC RESEARCH
- LncRNA PVT1 Enhances Proliferation and Cisplatin Resistance via Regulating miR-194-5p/HIF1a Axis in Oral Squamous Cell Carcinoma
- (2020) Fang Wang et al. OncoTargets and Therapy
- MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1
- (2020) Liqiang Chen et al. Bioengineered
- The miR-372-ZBTB7A Oncogenic Axis Suppresses TRAIL-R2 Associated Drug Sensitivity in Oral Carcinoma
- (2020) Li-Yin Yeh et al. Frontiers in Oncology
- Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma
- (2020) Danfeng Xue et al. Oxidative Medicine and Cellular Longevity
- lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway
- (2020) Ran Wang et al. OncoTargets and Therapy
- Broccoli extract increases drug-mediated cytotoxicity towards cancer stem cells of head and neck squamous cell carcinoma
- (2020) Osama A. Elkashty et al. BRITISH JOURNAL OF CANCER
- Circ_0109291 Promotes the Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase ABCB1 Expression
- (2020) Fei Gao et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin‐resistance, invasion and stemness acquisition
- (2020) Tanushree Kashyap et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
- (2020) Milad Ashrafizadeh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma
- (2020) Xiangwan Lu et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study
- (2020) Xu-Shan Sun et al. LANCET ONCOLOGY
- Cancer‐derived IgG involved in cisplatin resistance through PTP‐BAS/Src/PDK1/AKT signaling pathway
- (2020) Lu‐Ming Wang et al. ORAL DISEASES
- ZFAS1 Promotes Cisplatin Resistance via Suppressing miR-421 Expression in Oral Squamous Cell Carcinoma
- (2020) Xiaolong Wang et al. Cancer Management and Research
- Histone Deacetylase Inhibitor Sensitizes ERCC1-High Non-small-Cell Lung Cancer Cells to Cisplatin via Regulating miR-149
- (2020) Yuwen He et al. Molecular Therapy-Oncolytics
- ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer
- (2020) Maria Gebre-Medhin et al. JOURNAL OF CLINICAL ONCOLOGY
- Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway
- (2020) Ali Nasrollahzadeh et al. LIFE SCIENCES
- Direct Binding of Cisplatin to p22phox, an Endoplasmic Reticulum (ER) Membrane Protein, Contributes to Cisplatin Resistance in Oral Squamous Cell Carcinoma (OSCC) Cells
- (2020) Chih-Chang Hung et al. MOLECULES
- Cancer stemness of CD10‐positive cells regulated by Hedgehog pathway promotes the resistance to cisplatin in oral squamous cell carcinoma
- (2020) Yifei Wang et al. ORAL DISEASES
- Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
- (2020) Nuray Erin et al. DRUG RESISTANCE UPDATES
- Role of Nucleotide Excision Repair in Cisplatin Resistance
- (2020) Mingrui Duan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adaptation to Endoplasmic Reticulum Stress Enhances Resistance of Oral Cancer Cells to Cisplatin by Up-Regulating Polymerase η and Increasing DNA Repair Efficiency
- (2020) Cho-Yi Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Toll‐like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonists
- (2020) Ali Keshavarz et al. IUBMB LIFE
- Detection of human papillomavirus in oropharyngeal squamous cell carcinoma
- (2020) Fatin Hazwani Fauzi et al. Journal of Zhejiang University-SCIENCE B
- circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway
- (2020) Wei Gao et al. Molecular Cancer
- Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma
- (2020) Shuwei Chen et al. CANCER LETTERS
- Biological Functions of Autophagy Genes: A Disease Perspective
- (2019) Beth Levine et al. CELL
- Ovatodiolide Inhibits the Oncogenicity and Cancer Stem Cell-like Phenotype of Glioblastoma Cells, as well as Potentiate the Anticancer Effect of Temozolomide
- (2019) Yu-kai Su et al. PHYTOMEDICINE
- Survival outcomes after treatment of cancer of the oral cavity (1985–2015)
- (2019) Daniella Karassawa Zanoni et al. ORAL ONCOLOGY
- The effects of checkpoint inhibition on head and neck squamous cell carcinoma: A systematic review
- (2019) Mustafa Ghanizada et al. ORAL ONCOLOGY
- Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
- (2019) Irene Li et al. Molecular Cancer
- Cell death: a review of the major forms of apoptosis, necrosis and autophagy
- (2019) Mark S D’Arcy CELL BIOLOGY INTERNATIONAL
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway
- (2019) Bingyao Liu et al. Oncology Letters
- LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression
- (2019) Xiaoyan Wang et al. Biomed Research International
- miR-125b suppresses oral oncogenicity by targeting the anti-oxidative gene PRXL2A
- (2019) Yi-Fen Chen et al. Redox Biology
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- Exosomes and their role in tumorigenesis and anticancer drug resistance
- (2019) Neta Milman et al. DRUG RESISTANCE UPDATES
- Beyond Cisplatin: Combination Therapy with Arsenic Trioxide
- (2019) Ðenana Miodragović et al. INORGANICA CHIMICA ACTA
- Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines
- (2019) Hyeong Sim Choi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer stem cells: A review from origin to therapeutic implications
- (2019) Mohammad Reza Atashzar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Insights into new mechanisms and models of cancer stem cell multidrug resistance
- (2019) Y. Garcia-Mayea et al. SEMINARS IN CANCER BIOLOGY
- The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
- (2019) Ezra E. W. Cohen et al. Journal for ImmunoTherapy of Cancer
- Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
- (2019) Dharambir Kashyap et al. SEMINARS IN CANCER BIOLOGY
- Cisplatin-Resistance in Oral Squamous Cell Carcinoma: Regulation by Tumor Cell-Derived Extracellular Vesicles
- (2019) Xin-Hui Khoo et al. Cancers
- Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma
- (2019) Naoki Suenaga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting FAT1 Inhibits Carcinogenesis, Induces Oxidative Stress and Enhances Cisplatin Sensitivity through Deregulation of LRP5/WNT2/GSS Signaling Axis in Oral Squamous Cell Carcinoma
- (2019) Tung-Nien Hsu et al. Cancers
- PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
- (2019) Bin Shen et al. BRITISH JOURNAL OF CANCER
- Synthesis of novel N-vinylpyrrolidone/acrylic acid nanoparticles as drug delivery carriers of cisplatin to cancer cells
- (2019) Chaiyakarn Pornpitchanarong et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Progress in targeted therapeutic drugs for oral squamous cell carcinoma
- (2019) Lian Liu et al. SURGICAL ONCOLOGY-OXFORD
- Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy
- (2019) Francesco Perri et al. Translational Oncology
- Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
- (2019) Zixian Huang et al. Cell Death & Disease
- Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts
- (2019) Jia-Hong Chen et al. Cancers
- Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation
- (2018) Juan-kun Liao et al. BIOMEDICINE & PHARMACOTHERAPY
- Autophagy in health and disease: A comprehensive review
- (2018) Sarbari Saha et al. BIOMEDICINE & PHARMACOTHERAPY
- Classification de l’OMS 2017 des tumeurs de la tête et du cou : principales nouveautés et mise à jour des méthodes diagnostiques
- (2018) Victor Sarradin et al. BULLETIN DU CANCER
- Survivin expression in head and neck squamous cell carcinomas is frequent and correlates with clinical parameters and treatment outcomes
- (2018) Adrian Münscher et al. Clinical Oral Investigations
- miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling
- (2018) Meng Lu et al. DNA AND CELL BIOLOGY
- Arsenic trioxide: insights into its evolution to an anticancer agent
- (2018) Maneka Hoonjan et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Ursolic acid elicits intrinsic apoptotic machinery by downregulating the phosphorylation of AKT/BAD signaling in human cisplatin‑resistant oral cancer CAR cells
- (2018) Chin‑Fu Chen et al. ONCOLOGY REPORTS
- CerS6 regulates cisplatin resistance in oral squamous cell carcinoma by altering mitochondrial fission and autophagy
- (2018) Shengjiao Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- RNA interference of long noncoding RNA HOTAIR suppresses autophagy and promotes apoptosis and sensitivity to cisplatin in oral squamous cell carcinoma
- (2018) Xia Wang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas
- (2018) Shih-Shen Lin et al. Cancers
- STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma
- (2018) Santanu Maji et al. CARCINOGENESIS
- Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance
- (2018) Manzar Alam et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Differential resistance to platinum-based drugs and 5-fluorouracil in p22phox-overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies
- (2017) Chih-Chang Hung et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma
- (2017) Xiu-Juan Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Autophagy Induced by Areca Nut Extract Contributes to Decreasing Cisplatin Toxicity in Oral Squamous Cell Carcinoma Cells: Roles of Reactive Oxygen Species/AMPK Signaling
- (2017) Zhi Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells
- (2017) Wei Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Smoking cessation leads to changes in survivin expression in oral mucosa
- (2017) Celina F. Lima et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Cost-effectiveness Analysis of Nivolumab for Treatment of Platinum-Resistant Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- (2017) Kathryn R Tringale et al. JNCI-Journal of the National Cancer Institute
- The TLR3 Agonist Inhibit Drug Efflux and Sequentially Consolidates Low-Dose Cisplatin-Based Chemoimmunotherapy while Reducing Side Effects
- (2017) Liang Ding et al. MOLECULAR CANCER THERAPEUTICS
- Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
- (2017) Riccardo Mezzadra et al. NATURE
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum‐Containing Chemotherapy
- (2017) Erin Larkins et al. ONCOLOGIST
- Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression
- (2017) Li Yang et al. SEMINARS IN CANCER BIOLOGY
- Cost-effectiveness Analysis of Nivolumab for Treatment of Platinum-Resistant Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- (2017) Kathryn R Tringale et al. JNCI-Journal of the National Cancer Institute
- LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
- (2017) Zheng Fang et al. Cancer Medicine
- Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells
- (2017) Dongya Zhang et al. Scientific Reports
- miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer
- (2016) Jiong Lin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Oral Squamous Cell Carcinoma: Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and Therapy
- (2016) Sankalp A. Gharat et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling
- (2016) Chien-Han Yuan et al. ENVIRONMENTAL TOXICOLOGY
- Recent insights into the function of autophagy in cancer: Table 1.
- (2016) Ravi Amaravadi et al. GENES & DEVELOPMENT
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis
- (2016) Xiaofeng Qi et al. Scientific Reports
- Overexpression ofβ-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma
- (2016) Long Li et al. Biomed Research International
- MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulatingPTENandPDCD4
- (2016) Xueju Wei et al. Cancer Medicine
- MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features
- (2016) Ruma Dey Ghosh et al. Scientific Reports
- DNA damage response – A double-edged sword in cancer prevention and cancer therapy
- (2015) Hui Tian et al. CANCER LETTERS
- Lentivirus-Mediated RNAi Silencing Targeting ERCC1 Reverses Cisplatin Resistance in Cisplatin-Resistant Ovarian Carcinoma Cell Line
- (2015) Pei Du et al. DNA AND CELL BIOLOGY
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Survivin: A molecular biomarker in cancer
- (2015) RD Mittal et al. INDIAN JOURNAL OF MEDICAL RESEARCH
- Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III–IV unresectable head and neck cancer
- (2015) Zoltán Takácsi-Nagy et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma
- (2015) L Zhang et al. Cell Death & Disease
- p22phox confers resistance to cisplatin, by blocking its entry into the nucleus
- (2015) Chih-Chang Hung et al. Oncotarget
- Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
- (2015) Agnieszka Zimna et al. Biomed Research International
- A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy
- (2015) Zhi-Qi Wang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Combination of NTP with cetuximab inhibited invasion/migration of cetuximab-resistant OSCC cells: Involvement of NF-κB signaling
- (2015) Jae Won Chang et al. Scientific Reports
- Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
- (2014) Christos Kontos et al. Anti-Cancer Agents in Medicinal Chemistry
- Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer
- (2014) Hui Ji et al. CANCER SCIENCE
- MiR-222 Targeted PUMA to Improve Sensitization of UM1 Cells to Cisplatin
- (2014) Fangfang Jiang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes
- (2014) KOJI HARADA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53mut exhibits ATP-binding cassette transporter upregulation and high glutathione levels
- (2014) Manuel Tonigold et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
- (2014) K. Kian Ang et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4
- (2014) Wenhao Ren et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines
- (2014) WEI LI et al. Molecular Medicine Reports
- Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells
- (2014) Toshiki Nakaoka et al. CELLULAR ONCOLOGY
- A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
- (2013) R. Hitt et al. ANNALS OF ONCOLOGY
- Interplay between the Cancer Genome and Epigenome
- (2013) Hui Shen et al. CELL
- Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group
- (2013) Pierre Blanchard et al. JOURNAL OF CLINICAL ONCOLOGY
- The Yin and Yang of Toll-like receptors in cancer
- (2013) J-P Pradere et al. ONCOGENE
- Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies
- (2012) Laleh Amiri-Kordestani et al. DRUG RESISTANCE UPDATES
- Drug resistance: Still a daunting challenge to the successful treatment of AML
- (2012) Brian C. Shaffer et al. DRUG RESISTANCE UPDATES
- Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell Carcinoma
- (2012) Lai-ping Zhong et al. JOURNAL OF CLINICAL ONCOLOGY
- YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
- (2012) B. Kumar et al. MOLECULAR CANCER THERAPEUTICS
- Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy
- (2012) Ajay Ummat et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Subcellular targets of cisplatin cytotoxicity: An integrated view
- (2012) Sandra M. Sancho-Martínez et al. PHARMACOLOGY & THERAPEUTICS
- Microarray-Assisted Pathway Analysis Identifies MT1X & NFκB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma
- (2012) Bo Peng et al. PLoS One
- Purification and biochemical characterization of a novel protein—tongue cancer chemotherapy resistance-associated protein1 (TCRP1)
- (2012) Bo Peng et al. PROTEIN EXPRESSION AND PURIFICATION
- Sodium Arsenite ± Hyperthermia Sensitizes p53-Expressing Human Ovarian Cancer Cells to Cisplatin by Modulating Platinum-DNA Damage Responses
- (2012) Clarisse S. Muenyi et al. TOXICOLOGICAL SCIENCES
- Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines
- (2012) ULANA KOTOWSKI et al. Oncology Letters
- Hypoxia-inducible factors in OSCC
- (2011) Mario Pérez-Sayáns et al. CANCER LETTERS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line
- (2011) Yixue Gu et al. FEBS LETTERS
- High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area
- (2011) Tai-Jan Chiu et al. Journal of Translational Medicine
- Regulation of Excision Repair Cross-Complementation Group 1 by Snail Contributes to Cisplatin Resistance in Head and Neck Cancer
- (2010) D. S.-S. Hsu et al. CLINICAL CANCER RESEARCH
- Curcumin Enhances the Effect of Cisplatin in Suppression of Head and Neck Squamous Cell Carcinoma via Inhibition of IKK Protein of the NF B Pathway
- (2010) V. M. Duarte et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines
- (2010) Zhi-wei Yu et al. ORAL ONCOLOGY
- A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
- (2010) W J Placzek et al. Cell Death & Disease
- The Double-Edged Sword of Autophagy Modulation in Cancer
- (2009) E. White et al. CLINICAL CANCER RESEARCH
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search